190 related articles for article (PubMed ID: 26992212)
1. Tumor necrosis factor receptor 2-signaling in CD133-expressing cells in renal clear cell carcinoma.
Al-Lamki RS; Wang J; Yang J; Burrows N; Maxwell PH; Eisen T; Warren AY; Vanharanta S; Pacey S; Vandenabeele P; Pober JS; Bradley JR
Oncotarget; 2016 Apr; 7(17):24111-24. PubMed ID: 26992212
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor receptor expression and signaling in renal cell carcinoma.
Al-Lamki RS; Sadler TJ; Wang J; Reid MJ; Warren AY; Movassagh M; Lu W; Mills IG; Neal DE; Burge J; Vandenebeele P; Pober JS; Bradley JR
Am J Pathol; 2010 Aug; 177(2):943-54. PubMed ID: 20566746
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor receptor-2 signaling pathways promote survival of cancer stem-like CD133
Bradley JR; Wang J; Pacey S; Warren AY; Pober JS; Al-Lamki RS
FASEB Bioadv; 2020 Feb; 2(2):126-144. PubMed ID: 32123862
[TBL] [Abstract][Full Text] [Related]
4. TNFR1- and TNFR2-mediated signaling pathways in human kidney are cell type-specific and differentially contribute to renal injury.
Al-Lamki RS; Wang J; Vandenabeele P; Bradley JA; Thiru S; Luo D; Min W; Pober JS; Bradley JR
FASEB J; 2005 Oct; 19(12):1637-45. PubMed ID: 16195372
[TBL] [Abstract][Full Text] [Related]
5. Cytoplasmic expression of CD133 stemness marker is associated with tumor aggressiveness in clear cell renal cell carcinoma.
Saeednejad Zanjani L; Madjd Z; Abolhasani M; Andersson Y; Rasti A; Shariftabrizi A; Asgari M
Exp Mol Pathol; 2017 Oct; 103(2):218-228. PubMed ID: 29050853
[TBL] [Abstract][Full Text] [Related]
6. Signaling through tumor necrosis receptor 2 induces stem cell marker in CD133
Bradley JR; Wang J; Bardsley V; Broecker V; Thiru S; Pober JS; Al-Lamki RS
Am J Transplant; 2020 Sep; 20(9):2380-2391. PubMed ID: 32167668
[TBL] [Abstract][Full Text] [Related]
7. Generation of mouse macrophages expressing membrane-bound TNF variants with selectivity for TNFR1 or TNFR2.
Shibata H; Abe Y; Yoshioka Y; Nomura T; Sato M; Kayamuro H; Kawara T; Arita S; Furuya T; Nagano K; Yoshikawa T; Kamada H; Tsunoda S; Tsutsumi Y
Cytokine; 2010 Apr; 50(1):75-83. PubMed ID: 20045350
[TBL] [Abstract][Full Text] [Related]
8. TNF, acting through inducibly expressed TNFR2, drives activation and cell cycle entry of c-Kit+ cardiac stem cells in ischemic heart disease.
Al-Lamki RS; Lu W; Wang J; Yang J; Sargeant TJ; Wells R; Suo C; Wright P; Goddard M; Huang Q; Lebastchi AH; Tellides G; Huang Y; Min W; Pober JS; Bradley JR
Stem Cells; 2013 Sep; 31(9):1881-92. PubMed ID: 23712715
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor receptor 2: its contribution to acute cellular rejection and clear cell renal carcinoma.
Wang J; Al-Lamki RS
Biomed Res Int; 2013; 2013():821310. PubMed ID: 24350291
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of cancer stem cells in renal cell carcinoma.
Lucarelli G; Galleggiante V; Rutigliano M; Vavallo A; Ditonno P; Battaglia M
Urologia; 2015; 82(1):46-53. PubMed ID: 25451878
[TBL] [Abstract][Full Text] [Related]
11. TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure.
Ramesh G; Reeves WB
Am J Physiol Renal Physiol; 2003 Oct; 285(4):F610-8. PubMed ID: 12865254
[TBL] [Abstract][Full Text] [Related]
12. Type II tumour necrosis factor-alpha receptor (TNFR2) activates c-Jun N-terminal kinase (JNK) but not mitogen-activated protein kinase (MAPK) or p38 MAPK pathways.
Jupp OJ; McFarlane SM; Anderson HM; Littlejohn AF; Mohamed AA; MacKay RH; Vandenabeele P; MacEwan DJ
Biochem J; 2001 Nov; 359(Pt 3):525-35. PubMed ID: 11672426
[TBL] [Abstract][Full Text] [Related]
13. Activation of TNFR2 sensitizes macrophages for TNFR1-mediated necroptosis.
Siegmund D; Kums J; Ehrenschwender M; Wajant H
Cell Death Dis; 2016 Sep; 7(9):e2375. PubMed ID: 27899821
[TBL] [Abstract][Full Text] [Related]
14. TNFR1 delivers pro-survival signals that are required for limiting TNFR2-dependent activation-induced cell death (AICD) in CD8+ T cells.
Twu YC; Gold MR; Teh HS
Eur J Immunol; 2011 Feb; 41(2):335-44. PubMed ID: 21268004
[TBL] [Abstract][Full Text] [Related]
15. Contributions of angiotensin II and tumor necrosis factor-alpha to the development of renal fibrosis.
Guo G; Morrissey J; McCracken R; Tolley T; Liapis H; Klahr S
Am J Physiol Renal Physiol; 2001 May; 280(5):F777-85. PubMed ID: 11292619
[TBL] [Abstract][Full Text] [Related]
16. Lack of Evidence for a Direct Interaction of Progranulin and Tumor Necrosis Factor Receptor-1 and Tumor Necrosis Factor Receptor-2 From Cellular Binding Studies.
Lang I; Füllsack S; Wajant H
Front Immunol; 2018; 9():793. PubMed ID: 29740434
[TBL] [Abstract][Full Text] [Related]
17. Tumor biology of non-metastatic stages of clear cell renal cell carcinoma; overexpression of stearoyl desaturase-1, EPO/EPO-R system and hypoxia-related proteins.
Stoyanoff TR; Rodríguez JP; Todaro JS; Espada JD; Colavita JP; Brandan NC; Torres AM; Aguirre MV
Tumour Biol; 2016 Oct; 37(10):13581-13593. PubMed ID: 27468719
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the TNF-α Pathway in TKI Resistance and Suggestion of TNFR1 as a Predictive Biomarker for TKI Responsiveness in Clear Cell Renal Cell Carcinoma.
Hwang HS; Park YY; Shin SJ; Go H; Park JM; Yoon SY; Lee JL; Cho YM
J Korean Med Sci; 2020 Feb; 35(5):e31. PubMed ID: 32030920
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte macrophage-colony stimulating factor and interleukin-3 increase expression of type II tumour necrosis factor receptor, increasing susceptibility to tumour necrosis factor-induced apoptosis. Control of leukaemia cell life/death switching.
Rae C; MacEwan DJ
Cell Death Differ; 2004 Dec; 11 Suppl 2():S162-71. PubMed ID: 15459750
[TBL] [Abstract][Full Text] [Related]
20. Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma.
Griffith TS; Fialkov JM; Scott DL; Azuhata T; Williams RD; Wall NR; Altieri DC; Sandler AD
Cancer Res; 2002 Jun; 62(11):3093-9. PubMed ID: 12036919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
